Skip to main content
OpenTrials

Clinical trial condition

Recurrent Adult Diffuse Large Cell Lymphoma

Explore clinical trials studying Recurrent Adult Diffuse Large Cell Lymphoma. Study availability and eligibility vary by location and protocol.

94 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Adult Diffuse Large Cell Lymphoma trial results

Completed

PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

NCT00303953

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 123 locations
View Trial Details
Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • National Institutes of Health Bethesda, Maryland, United States
View Trial Details

Related conditions